Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
Year: 2008
Type: article
Study design: Clinical Trial
Source: Clinical Breast Cancer
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W1964092375
